Updated on 2024/09/10

写真a

 
NATORI Yutaka
 
Organization
School of Medicine (Clinical Medicine) Department of Medical Oncology Assistant Professor
Title
Assistant Professor

Degree

  • Doctor of Science ( 2007.3   The University of Tokyo )

Research History

  • Fukushima Medical University   School of Medicine (Clinical Medicine) Department of Medical Oncology   Assistant Professor

    2022.4 - Now

Papers

  • Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event.

    Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S

    Immunotherapy   1 - 10   2024.6( ISSN:1750-743X

      More details

    Authorship:Corresponding author   Language:English  

    DOI : 10.1080/1750743X.2024.2353539

    PubMed

  • Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event.

    Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S.

    Immunotherapy.   2024.6

      More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.1080/1750743X.2024.2353539.

  • E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer

    Natori Y, Suga J, Tokuda E, Tachibana K, Imai J, Honma R, Azami Y, Noda M, Sasaki E, Watanabe S, Ohtake T, Saji S.

    Cancers   15 ( 2 )   539   2023.1

      More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.3390/cancers15020539

  • がん免疫療法の診断と治療の現状と展望:がん抗体療法の進歩:乳がんHER2抗体薬物複合体などの抗体療法の現状と進歩

    名取 穣, 佐治 重衡

    Vita   40 ( 1 )   37 - 41   2023.1

      More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

  • A rare case of recurrent ovarian cancer with TPM3-NTRK1 gene rearrangement: A case report.

    Endo Y, Watanabe T, Saito M, Saito K, Suzuki R, Sano H, Natori Y, Sasaki E, Ueda M, Kamo N, Furukawa S, Soeda S, Kono K, Saji S, Fujimori K.

    Mol Clin Oncol   16 ( 4 )   90   2022.4

      More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.3892/mco.2022.2523.

  • 早期乳がんに対する2つのCDK4/6阻害薬 第Ⅲ相臨床試験の結果から:PALLAS試験とmonarchE試験

    名取 穣, 佐治 重衡

    がん分子標的治療   19 ( 1 )   112 - 115   2021.9

      More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

  • Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.

    Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S.

    J Immunother Cancer.   8 ( 2 )   e001164   2020.10

      More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.1136/jitc-2020-001164

  • 【新しい抗体薬;ADC】乳がんに対するADC

    名取 穣, 佐治 重衡

    がん分子標的治療   17 ( 2 )   128 - 132   2019.12( ISSN:1347-6955

      More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

  • 【医薬品副作用学(第3版)上-薬剤の安全使用アップデート-】薬効群別副作用 抗がん薬ホルモン療法薬(乳癌・前立腺癌・子宮体癌のホルモン療法薬)

    名取 穣, 佐治 重衡

    日本臨床   77 ( 増刊 3 )   94 - 99   2019.6

      More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

  • Imaging dynamics of endogenous mitochondrial RNA in single living cells

    Takeaki Ozawa, Yutaka Natori, Moritoshi Sato, Yoshio Umezawa

    Nature Methods   4 ( 5 )   413 - 419   2007.5( ISSN:1548-7091

      More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.1038/nmeth1030

    Other Link : http://www.nature.com/articles/nmeth1030

  • A Minimal Peptide Sequence That Targets Fluorescent and Functional Proteins into the Mitochondrial Intermembrane Space

    Takeaki Ozawa, Yutaka Natori, Yusuke Sako, Haruko Kuroiwa, Tsuneyoshi Kuroiwa, Yoshio Umezawa

    ACS Chemical Biology   2 ( 3 )   176 - 186   2007.3( ISSN:1554-8929

      More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.1021/cb600492a

  • A method for determining the activities of cytokines based on the nuclear transport of nuclear factor-κB

    Sung Bae Kim, Yutaka Natori, Takeaki Ozawa, Yoshio Umezawa, Hiroaki Tao

    Analytical Biochemistry   359 ( 1 )   147 - 149   2006.12( ISSN:0003-2697

      More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI : 10.1016/j.ab.2006.07.013

▼display all

Presentations

  • Human leukocyte antigen(HLA) type as a possible predictive marker for thyroid immune-related adverse event

    2024.2  

      More details

    Event date: 2024.2

  • A case of early-stage breast cancer performed pituitary function test 4 years after the onset of pituitary irAE

    2024.2  

      More details

    Event date: 2024.2

  • A case of Takotsubo cardiomyopathy during Lenvatinib treatment for papillary thyroid cancer

    2024.2  

      More details

    Event date: 2024.2

  • Pembrolizumab投与後に心筋炎を発症した、血管周囲性類上皮細胞腫瘍の1例

    第153回東北連合産科婦人科学会総会・学術講演会   2023.6  

      More details

    Event date: 2023.6

  • The exploratory case-control study on prediction of immune checkpoint inhibitor-induced thyroiditis by human leukocyte antigen types.

    2023 ASCO Annual Meeting   2023.6  

      More details

    Event date: 2023.6

  • Endocrine toxicities associated with Immune Checkpoint Inhibitors in breast cancer patients in our hospital.

    2023 the Japanese Society of Medical Oncology Annual Meeting -The 20th Anniversary Meeting-  

      More details

    Event date: 2023.3

  • HLA遺伝子型を用いた免疫関連有害事象のナルコレプシー発症のリスク評価

    第119回日本内科学会総会  

      More details

    Event date: 2022.4

  • Ubiquitin ligase NEDD4 promotes degradation of estrogen receptor in breast cancer and affects prognosis.

      More details

    Event date: 2022.2

  • 免疫チェックポイント阻害薬によるナルコレプシー発症のリスク

    第18回日本臨床腫瘍学会学術集会(JSMO2021)  

      More details

    Event date: 2021.3

  • Research for onset mechanism of Multiple Myeloma. Can B cell-derived iPS cells redifferentiate into B cells?

      More details

    Event date: 2021.3

  • ニボルマブ治療中に免疫性血小板減少性紫斑病を発症し治療に難渋した一例 P2-305

    第17回日本臨床腫瘍学会学術集会  

      More details

    Event date: 2019.7

  • 東日本大震災前後における福島県の部位別年齢階級別罹患率の動向〜がん検診を行っている5部位について〜(第2報)  P1-245

    第17回日本臨床腫瘍学会学術集会  

      More details

    Event date: 2019.7

▼display all